Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
NCT00720980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6
Last updated 2024-04-30
Summary
Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or disseminated form can occur. The etiology of granuloma annulare is unknown, however, multiple inciting factors have been proposed. The purpose of the investigators is to review the outcomes of treatment of granuloma annulare (GA) resistant to standard regimens that resolved after a 3-months treatment course of monthly rifampin, ofloxacin, and minocycline (ROM) therapy, successfully used to treat paucibacillary leprosy, a disease with clinical and histopathologic similarity to GA.
Conditions
- Granuloma Annulare
Sponsors & Collaborators
-
Henry Ford Health System
lead OTHER
Principal Investigators
-
Iltefat H Hamzavi, MD · Henry Ford Health System
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2008-05-31
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
NCT00196430 ·Status: COMPLETED ·Phase: PHASE3
-
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
NCT05535738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
NCT06934980 ·Status: COMPLETED
-
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405 ·Status: UNKNOWN
-
Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides
NCT06574204 ·Status: NOT_YET_RECRUITING
-
Assessment of Chilbains Occuring During Covid-19 Infection
NCT04344119 ·Status: RECRUITING
-
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
NCT04955951 ·Status: TERMINATED
-
Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration
NCT02493283 ·Status: COMPLETED ·Phase: PHASE1
-
Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers
NCT00001150 ·Status: COMPLETED
-
Skin Immunity Sample Collection Involving Blisters and Biopsies
NCT03921515 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
NCT00214851 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis
NCT01845987 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
NCT04369846 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
NCT02700373 ·Status: COMPLETED ·Phase: PHASE1
-
Hand Eczema in the Health Care Sector
NCT04449575 ·Status: UNKNOWN
-
Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica
NCT04492618 ·Status: COMPLETED ·Phase: PHASE2
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Register of Autoimmune Bullous Dermatoses
NCT02899923 ·Status: COMPLETED
-
Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and Therapy
NCT01967693 ·Status: COMPLETED
-
Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions
NCT05270512 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Bacitracin
NCT00132600 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Bacterial Toxins in Human Skin Disease
NCT02910791 ·Status: UNKNOWN
-
Etanercept for the Treatment of Chronic Urticaria
NCT01030120 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
NCT04202263 ·Status: UNKNOWN ·Phase: PHASE2
-
Cold Contact Urticaria Treatment With Rilonacept
NCT02171416 ·Status: COMPLETED ·Phase: PHASE2